TT
About
Tenax Therapeutics is a pharmaceutical company that focuses on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. Tenax Therapeutics develops novel dosing and formulations of imatinib mesylate, a kinase inhibitor for the treatment of pulmonary arterial hypertension. Imatinib, which acts on underlying cellular proliferative pathways linked to PAH, has the potential to be the first disease-modifying therapy for the disease.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 70 investors are based in Chapel Hill, North Carolina, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Chapel Hill, US
Contact Information
Find more investors like Tenax
Search Investors